EurekAlert! -
6 Jun 2016 06:00
(St. Jude Children's Research Hospital) St. Jude Children's Research Hospital reports that higher blood concentrations of methotrexate during cancer treatment are associated with brain changes and impaired executive function in survivors of pediatric leukemia.
Share this Article